xDRIVE for Florida-based Cancer Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

April 1, 2027

Conditions
CancerNeoplamsRefractoryRecurrenceLeukaemiaLymphomaSolid Tumor MalignanciesSolid Cancers
Interventions
DIAGNOSTIC_TEST

xDRIVE Tumor Profiling

Patients and physicians will receive tumor profiling data via xDRIVE Functional Precision Medicine and Artificial Intelligence analysis. As this is a feasibility study, results will be returned to the physician and the physician may use the data to inform the next line of treatment.

All Listed Sponsors
lead

First Ascent Biomedical Inc.

INDUSTRY